Overview
Status
Active
Registry date
2023-09-26
Share capital
10,000.00 PLN
Registered address
Aleja Jana Pawła II 43A/37b, 01-001 Warszawa, Poland
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Authorized Representatives
Divya Jimmy Luke – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Divya Jimmy Lukeage 39 | 100 | $2,701.24 | 100% |
Beneficial owners
No beneficial owners recorded for the company Unicorn Series.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Celon PharmaS.A. | $1,530,249,310.95 | celonpharma.com | ||
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com |
FAQ
The main business activity of Unicorn Series focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on September 26, 2023.
The headquarters is located at: Aleja Jana Pawła Ii 43A, 01-001 Warszawa.
The share capital of the company is PLN 10,000 (approx. $2,701).
Last updated: 2026-10-07